Cargando…
EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells
Epithelial-mesenchymal transition (EMT) can contribute to tumor invasion, metastasis, and resistance to chemotherapy or hormone therapy. EMT may be induced by a variety of growth factors, such as epidermal growth factor (EGF). Most studies regarding EMT have focused on TGF-β-Smads signaling. The mec...
Autores principales: | Kim, Jinkyoung, Kong, Jienan, Chang, Hyeyoon, Kim, Hayeon, Kim, Aeree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356716/ https://www.ncbi.nlm.nih.gov/pubmed/27829223 http://dx.doi.org/10.18632/oncotarget.13116 |
Ejemplares similares
-
HRG-β1-driven ErbB3 signaling induces epithelial–mesenchymal transition in breast cancer cells
por: Kim, Jinkyoung, et al.
Publicado: (2013) -
A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial–Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK
por: Jeong, Ji-Hoon, et al.
Publicado: (2020) -
Clear Cell Renal Cell Carcinoma with Intratumoral Granulomatous Reaction: A Case Report and Review of the Literature
por: Kim, Hayeon, et al.
Publicado: (2017) -
LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-β1/Smad/Snail Pathway
por: Xue, Qingming, et al.
Publicado: (2021) -
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
por: Lundgren, K, et al.
Publicado: (2009)